Unknown

Dataset Information

0

Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics.


ABSTRACT: Purpose:To systematically evaluate human rod opsin (hRHO) mRNA for potential target sites sensitive to posttranscriptional gene silencing (PTGS) by hammerhead ribozyme (hhRz) or RNA interference (RNAi) in human cells. To develop a comprehensive strategy to identify and optimize lead candidate agents for PTGS gene therapeutics. Methods:In multidisciplinary RNA drug discovery, computational mRNA accessibility and in vitro experimental methods using reverse transcription-polymerase chain reaction (RT-PCR) were used to map accessibility in full-length hRHO transcripts. HhRzs targeted predicted accessible and inaccessible sites and were screened for cellular knockdown using a bicistronic reporter construct. Lead hhRz and RNAi PTGS agents were rationally optimized for target knockdown in human cells. Results:Systematic screening of hRHO mRNA targeting agents resulted in lead candidate identification of a novel hhRz embedded in an RNA scaffold. Rational optimization strategies identified a minimal 725 hhRz as the most active agent. Recently identified tertiary accessory elements did not enhance activity. A 725-short-hairpin RNA (shRNA) agent exerts log-order knockdown. Silent modulation of the 725-hhRz target site in hRHO mRNA resulted in resistance to knockdown. Conclusions:Combining rational RNA drug design with cell-based screening allowed rapid identification of lead agents targeting hRHO. Optimization strategies identified the agent with highest intracellular activity. These agents have therapeutic potential in a mutation-independent strategy for adRP, or other degenerations where hRHO is a target. This approach can be broadly applied to any validated target mRNA, regardless of the disease. Translational Relevance:This work establishes a platform approach to develop RNA biologicals for the treatment of human disease.

SUBMITTER: Yau EH 

PROVIDER: S-EPMC6908138 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics.

Yau Edwin H EH   Taggart Robert T RT   Zuber Mohammed M   Trujillo Alexandria J AJ   Fayazi Zahra S ZS   Butler Mark C MC   Sheflin Lowell G LG   Breen Jennifer B JB   Yu Dian D   Sullivan Jack M JM  

Translational vision science & technology 20191101 6


<h4>Purpose</h4>To systematically evaluate human rod opsin (<i>hRHO</i>) mRNA for potential target sites sensitive to posttranscriptional gene silencing (PTGS) by hammerhead ribozyme (hhRz) or RNA interference (RNAi) in human cells. To develop a comprehensive strategy to identify and optimize lead candidate agents for PTGS gene therapeutics.<h4>Methods</h4>In multidisciplinary RNA drug discovery, computational mRNA accessibility and in vitro experimental methods using reverse transcription-polym  ...[more]

Similar Datasets

| S-EPMC2889565 | biostudies-literature
| S-EPMC3442401 | biostudies-literature
| S-EPMC5025264 | biostudies-literature
| S-EPMC2610292 | biostudies-literature
| S-EPMC4540256 | biostudies-literature
| S-EPMC4795032 | biostudies-literature
| S-EPMC2787460 | biostudies-literature
2023-06-24 | GSE206853 | GEO
| S-EPMC6527159 | biostudies-literature
| S-EPMC9421652 | biostudies-literature